UroGen Pharma CMO Mark Schoenberg sells 10,000 shares for $400,100
URGN•Insider share sale disclosed
- UroGen Pharma Chief Medical Officer Mark Schoenberg sold 10,000 ordinary shares on July 9 at a weighted average price of $40.
- His direct holding fell to 119,763 ordinary shares following the transaction.
